![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 36, 34458-34466, September 5, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 and RXR
Cooperate for Triggering the Transactivation and the Degradation of RAR
2/RXR
Heterodimers*


From the Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) CNRS INSERM ULP, UMR 7104, BP 10142, 67404 Illkirch Cedex, France and ¶Laboratorio di Biologia Molecolare, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italy
In eukaryotic cells, liganded RAR
2/RXR
heterodimers activate
the transcription of retinoic acid (RA) target genes and then are degraded
through the ubiquitin-proteasome pathway. In this study, we dissected the role
of the RAR
2 and RXR
partners as well as of their respective AF-1
and AF-2 domains in the processes of transactivation and degradation.
RAR
2 is the "engine" initiating transcription and its own
degradation subsequent to ligand binding. Integrity of its AF-2 domain and
phosphorylation of its AF-1 domain are required for both the degradation and
the transactivation of the receptor. Deletion of the whole AF-1 domain does
not impair these processes but shifts the receptor toward other proteolytic
pathways through RXR
. In contrast, RXR
plays only a modulatory
role, cooperating with RAR
2 through its AF-2 domain and its
phosphorylated AF-1 domain in both the transcription activity and the
degradation of the RAR
2/RXR
heterodimers. Our results underline
that the AF-1 and AF-2 domains of each heterodimer partner cooperate with one
other and that this cooperation is relevant for both the transcription and
degradation processes.
Received for publication, May 12, 2003 , and in revised form, June 23, 2003.
* This work was supported by funds from CNRS, INSERM, the Collège de France, the Hôpital Universitaire de Strasbourg, the Association pour la Recherche sur le Cancer, and Bristol-Myers Squibb. This work was also supported by the "Associazione Italiana per la Ricerca contro il Cancro," the "Progetto Finalizzato Oncologia," Consiglio Nazionale delle Ricerche-Ministero dell'Università e della Ricerca Scientifica e Technologica, and the "Fondo d'Investimento per la Ricerca Biotecnologica." The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by short term fellowships from Human Frontier Science Program,
the Association pour la Recherche sur le Cancer, and the Fondazione Italiana
per la Ricerca sul Cancro. Present adress: Laboratorio di Biologia Molecolare,
Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano,
Italy.
Supported by the "Ligue Nationale contre le Cancer." Present
address: Neurogénétique Moléculaire, E.O223,
Génopole, 2 rue Gaston Crémieux, 91057 Evry Cedex, France.
|| To whom correspondence should be addressed: IGBMC, BP 10142, 67 404 Illkirch Cedex, CU de Strasbourg, France. Tel.: 33-3-88-65-34-59; Fax: 33-3-88-65-32-01; E-mail: cegly{at}igbmc.u-strasbg.fr.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Z. Vucetic, Z. Zhang, J. Zhao, F. Wang, K. J. Soprano, and D. R. Soprano Acinus-S' Represses Retinoic Acid Receptor (RAR)-Regulated Gene Expression through Interaction with the B Domains of RARs Mol. Cell. Biol., April 15, 2008; 28(8): 2549 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lattuada, P. Vigano, S. Mangioni, J. Sassone, S. Di Francesco, M. Vignali, and A. M. Di Blasio Accumulation of Retinoid X Receptor-{alpha} in Uterine Leiomyomas Is Associated with a Delayed Ligand-Dependent Proteasome-Mediated Degradation and an Alteration of Its Transcriptional Activity Mol. Endocrinol., March 1, 2007; 21(3): 602 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Bogoyevitch and B. Kobe Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases Microbiol. Mol. Biol. Rev., December 1, 2006; 70(4): 1061 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Narayanan, V. A. T. Sepulveda, M. Falzon, and N. L. Weigel The Functional Consequences of Cross-talk between the Vitamin D Receptor and ERK Signaling Pathways Are Cell-specific J. Biol. Chem., November 5, 2004; 279(45): 47298 - 47310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D.-C. Arce, U. Soto, J. van Riggelen, E. Schwarz, H. z. Hausen, and F. Rosl Ectopic Expression of Nonliganded Retinoic Acid Receptor {beta} Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells J. Biol. Chem., October 29, 2004; 279(44): 45408 - 45416. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |